Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma
Clinical trial NCT02234115 · COMPLETED
Trial details
- NCT number
- NCT02234115
- Sponsor
- Foresee Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2016-08-30
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.